HHealthcare Read More Johnson & Johnson halts mid-stage trial of experimental eczema drugDecember 26, 2025 Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
PPersonal finance Read More 5 Dividend Powerhouses That Belong in Every Retirement Portfolio Right NowDecember 11, 2025 24/7 Wall St Verizon offers the highest yield at 6.59% with a 0.32 beta and 19 consecutive years…
AArtificial intelligence Read More Google’s Gemini puts OpenAI on shakier ground, with big market implicationsNovember 24, 2025 Almost every night, for almost a decade, I got a phone call between 7:00 and 7:01 p.m. ET.…
MMedication Read More Trump, RFK Jr. and Texas lawsuits slam KenvueNovember 6, 2025 Kenvue, the company that makes Tylenol, is fighting on both the political and scientific fronts. The latest blow…
MMedication Read More Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands dealNovember 3, 2025 Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a…
MMedication Read More Texas sues Tylenol makers over RFK Jr autism claims saying they failed to state ‘risk of taking drug while pregnant’October 31, 2025 Texas has launched a lawsuit against manufacturers of Tylenol, claiming they deceived customers by failing to mention unproven…
MMedication Read More Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug’s autism risksOctober 28, 2025 (Reuters) -The makers of Tylenol, Johnson & Johnson and Kenvue, were sued on Tuesday by Texas Attorney General…
HHealthcare Read More J&J in talks to acquire Protagonist TherapeuticsOctober 13, 2025 Johnson & Johnson (J&J) is in discussions to purchase Protagonist Therapeutics, a move that would enhance their current…
HHealthcare Read More Johnson & Johnson ordered to pay $966 million after jury finds company liable in talc cancer caseOctober 7, 2025 In this photo illustration, a container of Johnson’s baby powder made by Johnson and Johnson sits on a…
HHealthcare Read More Trump pharmaceutical tariff threat lessens after Pfizer dealOctober 1, 2025 U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with…
HHealthcare Read More Johnson & Johnson’s Shareholder Supremacy In HealthcareOctober 1, 2025 IRVINE, CALIFORNIA – OCTOBER 17: The Johnson & Johnson logo is displayed at company offices on October 17,…
AArtificial intelligence Read More Why the crazy spending of this AI boom isn’t like the dot-com bubbleSeptember 28, 2025 If I hear one more hedge fund oligarch on television tell me that the data center buildout/artificial intelligence…